Legal & General Group PLC Portage Biotech Inc. Transaction History

Legal & General Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$5.16 - $11.95 $2,193 - $5,078	-425 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.65 - $22.4 $1,870 - $3,068	137 Added 47.57%	425 $9,000
Q2 2021 Aug 12, 2021	BUY	$20.96 - $42.81 $6,036 - $12,329	288 New	288 $6,000

28.4K

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $69.8M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.